PPA: Clinical Trials

1 trial for PPA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow PPA: new trials by email Literature Review of PPA trials Research Report on PPA

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PiB PET Scanning in Speech and Language Based Dementias
C-11 PiB, F-18 FDG - PPA, Primary Progressive Aphasia
Phase 1CompletedMayo Clinic1682010-03-012015-12-22

Narrower conditions

Aphasia (1)  ·  Aphasia, Broca (1)  ·  Aphasia, Primary Progressive (1)  ·  Apraxias (1)  ·  Frontotemporal Dementia (1)  ·  Language (1)  ·  Primary Progressive Nonfluent Aphasia (1)

Broader conditions

Behavior (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Communication (1)  ·  Communication Disorders (1)  ·  Dementia (1)  ·  Frontotemporal Lobar Degeneration (1)  ·  Language Disorders (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)

Interventions

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (1)

Sponsors

Mayo Clinic (1)

Countries

United States (1)

Top investigators

Keith A Josephs, M.D. MST, MSc (1)